BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17064862)

  • 1. Topical delivery of N-alkyl-N-alkyloxycarbonylaminomethyl (NANAOCAM) prodrugs of theophylline (ThH).
    Majumdar S; Sloan KB
    Int J Pharm; 2007 Mar; 332(1-2):64-71. PubMed ID: 17064862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and topical delivery of N-alkyl-N-alkyloxycarbonylaminomethyl prodrugs of a model phenolic drug: acetaminophen.
    Majumdar S; Sloan KB
    Int J Pharm; 2007 Jun; 337(1-2):48-55. PubMed ID: 17257787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical delivery of a model phenolic drug: alkyloxycarbonyl prodrugs of acetaminophen.
    Wasdo SC; Sloan KB
    Pharm Res; 2004 Jun; 21(6):940-6. PubMed ID: 15212157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-alkylcarbonyl and 7-alkyloxycarbonyl prodrugs of theophylline.
    Sloan KB; DellaVecchia SA; Estes JV; Roberts WJ
    Int J Pharm; 2000 Sep; 205(1-2):53-63. PubMed ID: 11000542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft alkyl ether prodrugs of a model phenolic drug: the effect of incorporation of ethyleneoxy groups on transdermal delivery.
    Thomas JD; Majumdar S; Sloan KB
    Molecules; 2009 Oct; 14(10):4231-45. PubMed ID: 19924060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs.
    Roberts WJ; Sloan KB
    J Pharm Sci; 2003 May; 92(5):1028-36. PubMed ID: 12712422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal delivery.
    Majumdar S; Mueller-Spaeth M; Sloan KB
    AAPS PharmSciTech; 2012 Sep; 13(3):853-62. PubMed ID: 22648150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Alkyl-N-alkyloxycarbonylaminomethyl (NANAOCAM) prodrugs of carboxylic acid containing drugs.
    Majumdar S; Sloan KB
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1447-50. PubMed ID: 17196386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the fit of flux through hairless mouse skin from water data to three model equations.
    Wasdo SC; Juntunen J; Devarajan H; Sloan KB
    Int J Pharm; 2009 Jan; 366(1-2):65-73. PubMed ID: 18824227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of alkyloxycarbonyloxymethyl (AOCOM) ethers as novel prodrugs of phenols for topical delivery: AOCOM prodrugs of acetaminophen.
    Thomas JD; Sloan KB
    Int J Pharm; 2009 Apr; 371(1-2):25-32. PubMed ID: 19136050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkylation of 6-mercaptopurine (6-MP) with N-alkyl-N-alkoxycarbonylaminomethyl chlorides: S6-(N-alkyl-N-alkoxycarbonyl)aminomethyl-6-MP prodrug structure effect on the dermal delivery of 6-MP.
    Siver KG; Sloan KB
    J Pharm Sci; 1990 Jan; 79(1):66-73. PubMed ID: 2313580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of alkylcarbonyloxymethyl (ACOM) ethers as novel prodrugs of phenols for topical delivery: ACOM prodrugs of acetaminophen.
    Thomas JD; Sloan KB
    Int J Pharm; 2008 Jan; 346(1-2):80-8. PubMed ID: 17629641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing for topical delivery: prodrugs can make the difference.
    Sloan KB; Wasdo S
    Med Res Rev; 2003 Nov; 23(6):763-93. PubMed ID: 12939791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical delivery of 5-fluorouracil (5-FU) by 1,3-bisalkylcarbonyl-5-FU prodrugs.
    Beall HD; Sloan KB
    Int J Pharm; 2002 Jan; 231(1):43-9. PubMed ID: 11719012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Alkylcarbonyloxymethyl prodrugs of 5-fluorouracil (5-FU): synthesis, physicochemical properties, and topical delivery of 5-FU.
    Taylor HE; Sloan KB
    J Pharm Sci; 1998 Jan; 87(1):15-20. PubMed ID: 9452962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, hydrolyses and dermal delivery of N-alkyl-N-alkyloxycarbonylaminomethyl (NANAOCAM) derivatives of phenol, imide and thiol containing drugs.
    Majumdar S; Sloan KB
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3590-4. PubMed ID: 16616488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model.
    Roberts WJ; Sloan KB
    J Pharm Sci; 2000 Nov; 89(11):1415-31. PubMed ID: 11015687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts-Guy approach.
    Roberts WJ; Sloan KB
    J Pharm Sci; 1999 May; 88(5):515-22. PubMed ID: 10229642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lipid and aqueous solubilities on flux of nicotinic acid esters from water through silicone membrane.
    Synovec J; Wasdo SC; Sloan KB
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1494-7. PubMed ID: 22676485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Mannich-base prodrugs of 5-iodo-2'-deoxycytidine as topical delivery enhancers.
    Koch SA; Sloan KB
    Pharm Res; 1987 Aug; 4(4):317-20. PubMed ID: 3508538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.